BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 9833019)

  • 1. Assessment of the discriminative stimulus effects of the D3 dopamine antagonist PNU-99194A in rats: comparison with psychomotor stimulants.
    Baker LE; Miller ME; Svensson KA
    Behav Pharmacol; 1997 Jun; 8(2-3):243-52. PubMed ID: 9833019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The dopamine D3 receptor antagonist PNU-99194A fails to block (+)-7-OH-DPAT substitution for D-amphetamine or cocaine.
    Baker LE; Svensson KA; Garner KJ; Goodwin AK
    Eur J Pharmacol; 1998 Oct; 358(2):101-9. PubMed ID: 9808258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Common discriminative stimulus properties in rats of muscarinic antagonists, clozapine and the D3 preferring antagonist PNU-99194a: an analysis of possible mechanisms.
    Goudie AJ; Baker LE; Smith JA; Prus AJ; Svensson KA; Cortes-Burgos LA; Wong EH; Haadsma-Svensson S
    Behav Pharmacol; 2001 Sep; 12(5):303-15. PubMed ID: 11710745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of dopamine receptor subtypes in the discriminative stimulus effects of amphetamine and cocaine in rats.
    Filip M; Przegaliński E
    Pol J Pharmacol; 1997; 49(1):21-30. PubMed ID: 9431548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of D2 and D3 receptor-selective ligands in rats trained to discriminate cocaine from saline.
    Garner KJ; Baker LE
    Pharmacol Biochem Behav; 1999 Oct; 64(2):373-8. PubMed ID: 10515316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acquisition of nicotine discrimination and discriminative stimulus effects of nicotine in rats chronically exposed to caffeine.
    Gasior M; Shoaib M; Yasar S; Jaszyna M; Goldberg SR
    J Pharmacol Exp Ther; 1999 Mar; 288(3):1053-73. PubMed ID: 10027843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antagonism of the discriminative stimulus effects of cocaine at two training doses by dopamine D2-like receptor antagonists.
    Costanza RM; Barber DJ; Terry P
    Psychopharmacology (Berl); 2001 Nov; 158(2):146-53. PubMed ID: 11702088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reevaluation of PNU-99194A discriminative stimulus effects: potentiation by both a D2 antagonist and a D3/D2 agonist.
    Baker LE; Prus AJ
    Pharmacol Biochem Behav; 2002 Nov; 73(4):753-8. PubMed ID: 12213519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discriminative stimulus properties of the dopamine D3 antagonist PNU-99194A.
    Franklin SR; Baker LE; Svensson KA
    Psychopharmacology (Berl); 1998 Jul; 138(1):40-6. PubMed ID: 9694525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antagonism of the discriminative stimulus effects of (+)-7-OH-DPAT by remoxipride but not PNU-99194A.
    Christian AJ; Goodwin AK; Baker LE
    Pharmacol Biochem Behav; 2001 Mar; 68(3):371-7. PubMed ID: 11325388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cocaine-induced locomotor activity and cocaine discrimination in dopamine D2 receptor mutant mice.
    Chausmer AL; Elmer GI; Rubinstein M; Low MJ; Grandy DK; Katz JL
    Psychopharmacology (Berl); 2002 Aug; 163(1):54-61. PubMed ID: 12185400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of D3 versus D2 receptor modulation of the discriminative stimulus effects of (+)-7-OH-DPAT in rats.
    Baker LE; Hood CA; Heidema AM
    Behav Pharmacol; 1999 Dec; 10(8):717-22. PubMed ID: 10780286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of d-amphetamine and caffeine in humans under a cocaine discrimination procedure.
    Oliveto AH; McCance-Katz E; Singha A; Hameedi F; Kosten TR
    Behav Pharmacol; 1998 May; 9(3):207-17. PubMed ID: 9832935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of adenosine A1 and A2A receptors in the adenosinergic modulation of the discriminative-stimulus effects of cocaine and methamphetamine in rats.
    Justinova Z; Ferre S; Segal PN; Antoniou K; Solinas M; Pappas LA; Highkin JL; Hockemeyer J; Munzar P; Goldberg SR
    J Pharmacol Exp Ther; 2003 Dec; 307(3):977-86. PubMed ID: 14557381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The D3 antagonist PNU-99194A potentiates the discriminative cue produced by the D3 agonist 7-OH-DPAT.
    Depoortere R; Perrault G; Sanger DJ
    Pharmacol Biochem Behav; 2000 Jan; 65(1):31-4. PubMed ID: 10638632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of perinatal exposure to lead on the discriminative stimulus properties of cocaine and related drugs in rats.
    Miller DK; Nation JR; Bratton GR
    Psychopharmacology (Berl); 2001 Nov; 158(2):165-74. PubMed ID: 11702090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine D3 receptor agonists partially reproduce the discriminative stimulus effects of cocaine in squirrel monkeys.
    Spealman RD
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1128-37. PubMed ID: 8819495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of eticlopride and the selective D3-antagonist PNU 99194-A on food- and cocaine-maintained responding in rhesus monkeys.
    Claytor R; Lile JA; Nader MA
    Pharmacol Biochem Behav; 2006 Mar; 83(3):456-64. PubMed ID: 16631246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anxiolytic-like effect of nafadotride and PNU 99194A, dopamine D3 receptor antagonists in animal models.
    Rogóz Z; Kłodzińska A; Maj J
    Pol J Pharmacol; 2000; 52(6):459-62. PubMed ID: 11334239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonin1B receptor ligands in the nucleus accumbens shell do not affect the discriminative stimulus effects of amphetamine in rats.
    Filip M; Nowak E; Baran L; Przegaliński E
    Pol J Pharmacol; 2001; 53(5):449-57. PubMed ID: 11990062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.